These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23843692)

  • 1. S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis.
    Mazo DF; de Oliveira MG; Pereira IV; Cogliati B; Stefano JT; de Souza GF; Rabelo F; Lima FR; Ferreira Alves VA; Carrilho FJ; de Oliveira CP
    Drug Des Devel Ther; 2013; 7():553-63. PubMed ID: 23843692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S-nitroso-N-acetylcysteine attenuates liver fibrosis in cirrhotic rats.
    Vercelino R; Crespo I; de Souza GF; Cuevas MJ; de Oliveira MG; Marroni NP; González-Gallego J; Tuñón MJ
    J Mol Med (Berl); 2010 Apr; 88(4):401-11. PubMed ID: 20062961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral administration of S-nitroso-N-acetylcysteine prevents the onset of non alcoholic fatty liver disease in rats.
    de Oliveira CP; Simplicio FI; de Lima VM; Yuahasi K; Lopasso FP; Alves VA; Abdalla DS; Carrilho FJ; Laurindo FR; de Oliveira MG
    World J Gastroenterol; 2006 Mar; 12(12):1905-11. PubMed ID: 16609997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention and reversion of nonalcoholic steatohepatitis in OB/OB mice by S-nitroso-N-acetylcysteine treatment.
    de Oliveira CP; de Lima VM; Simplicio FI; Soriano FG; de Mello ES; de Souza HP; Alves VA; Laurindo FR; Carrilho FJ; de Oliveira MG
    J Am Coll Nutr; 2008 Apr; 27(2):299-305. PubMed ID: 18689562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S-Nitroso-N-acetylcysteine induces de-differentiation of activated hepatic stellate cells and promotes antifibrotic effects in vitro.
    Stefano JT; Cogliati B; Santos F; Lima VM; Mazo DC; Matte U; Alvares-da-Silva MR; Silveira TR; Carrilho FJ; Oliveira CP
    Nitric Oxide; 2011 Oct; 25(3):360-5. PubMed ID: 21820071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S-nitroso-N-acetylcysteine ameliorates ischemia-reperfusion injury in the steatotic liver.
    Andraus W; Souza GF; Oliveira MG; Haddad LB; Coelho AM; Galvão FH; Leitão RM; D'Albuquerque LA; Machado MC
    Clinics (Sao Paulo); 2010 Jul; 65(7):715-21. PubMed ID: 20668630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice.
    Csak T; Velayudham A; Hritz I; Petrasek J; Levin I; Lippai D; Catalano D; Mandrekar P; Dolganiuc A; Kurt-Jones E; Szabo G
    Am J Physiol Gastrointest Liver Physiol; 2011 Mar; 300(3):G433-41. PubMed ID: 21233280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic gene expression profile associated with non-alcoholic steatohepatitis protection by S-nitroso-N-acetylcysteine in ob/ob mice.
    de Oliveira CP; Stefano JT; de Lima VM; de Sá SV; Simplicio FI; de Mello ES; Corrêa-Giannella ML; Alves VA; Laurindo FR; de Oliveira MG; Giannella-Neto D; Carrilho FJ
    J Hepatol; 2006 Nov; 45(5):725-33. PubMed ID: 16935387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of hepatic microsomal triglyceride transfer protein (MTP) induced by S-nitroso-N-acetylcysteine in ob/ob mice.
    Oliveira CP; Alves VA; Lima VM; Stefano JT; Debbas V; Sá SV; Wakamatsu A; Corrêa-Giannella ML; de Mello ES; Havaki S; Tiniakos DG; Marinos E; de Oliveira MG; Giannella-Neto D; Laurindo FR; Caldwell S; Carrilho FJ
    Biochem Pharmacol; 2007 Jul; 74(2):290-7. PubMed ID: 17524368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sorafenib prevents liver fibrosis in a non-alcoholic steatohepatitis (NASH) rodent model.
    Stefano JT; Pereira IV; Torres MM; Bida PM; Coelho AM; Xerfan MP; Cogliati B; Barbeiro DF; Mazo DF; Kubrusly MS; D'Albuquerque LA; Souza HP; Carrilho FJ; Oliveira CP
    Braz J Med Biol Res; 2015 May; 48(5):408-14. PubMed ID: 25714891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentoxifylline does not prevent neither liver damage nor early profibrogenic events in a rat model of non-alcoholic steatohepatitis.
    Vial P; Riquelme A; Pizarro M; Solís N; Madariaga JA; Aguayo G; Duarte I; Soza A; Accatino L; Arrese M
    Ann Hepatol; 2006; 5(1):25-9. PubMed ID: 16531961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified synthetic siRNA targeting tissue inhibitor of metalloproteinase-2 inhibits hepatic fibrogenesis in rats.
    Hu YB; Li DG; Lu HM
    J Gene Med; 2007 Mar; 9(3):217-29. PubMed ID: 17351970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor binding protein related protein 1 knockdown attenuates hepatic fibrosis via the regulation of MMPs/TIMPs in mice.
    Ren JJ; Huang TJ; Zhang QQ; Zhang HY; Guo XH; Fan HQ; Li RK; Liu LX
    Hepatobiliary Pancreat Dis Int; 2019 Feb; 18(1):38-47. PubMed ID: 30243878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination treatment of angiotensin II type I receptor blocker and new oral iron chelator attenuates progression of nonalcoholic steatohepatitis in rats.
    Kaji K; Yoshiji H; Kitade M; Ikenaka Y; Noguchi R; Shirai Y; Aihara Y; Namisaki T; Yoshii J; Yanase K; Tsujimoto T; Kawaratani H; Fukui H
    Am J Physiol Gastrointest Liver Physiol; 2011 Jun; 300(6):G1094-104. PubMed ID: 21372165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of N-acetylcysteine on oxidative stress in rats with non-alcoholic steatohepatitis.
    Samuhasaneeto S; Thong-Ngam D; Kulaputana O; Patumraj S; Klaikeaw N
    J Med Assoc Thai; 2007 Apr; 90(4):788-97. PubMed ID: 17487136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice.
    Velayudham A; Dolganiuc A; Ellis M; Petrasek J; Kodys K; Mandrekar P; Szabo G
    Hepatology; 2009 Mar; 49(3):989-97. PubMed ID: 19115316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet.
    Kawaguchi K; Sakaida I; Tsuchiya M; Omori K; Takami T; Okita K
    Biochem Biophys Res Commun; 2004 Feb; 315(1):187-95. PubMed ID: 15013444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aerobic exercise training in the treatment of non-alcoholic fatty liver disease related fibrosis.
    Linden MA; Sheldon RD; Meers GM; Ortinau LC; Morris EM; Booth FW; Kanaley JA; Vieira-Potter VJ; Sowers JR; Ibdah JA; Thyfault JP; Laughlin MH; Rector RS
    J Physiol; 2016 Sep; 594(18):5271-84. PubMed ID: 27104887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human amnion epithelial cells and their soluble factors reduce liver fibrosis in murine non-alcoholic steatohepatitis.
    Kuk N; Hodge A; Sun Y; Correia J; Alhomrani M; Samuel C; Moore G; Lim R; Sievert W
    J Gastroenterol Hepatol; 2019 Aug; 34(8):1441-1449. PubMed ID: 30821873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polaprezinc attenuates liver fibrosis in a mouse model of non-alcoholic steatohepatitis.
    Sugino H; Kumagai N; Watanabe S; Toda K; Takeuchi O; Tsunematsu S; Morinaga S; Tsuchimoto K
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1909-16. PubMed ID: 18422963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.